ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,022Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 16

$6,285 Total Retail Price of All Prescriptions

Rank: 15 out of 16

285 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 285 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

24% of this provider’s 285 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 16,942 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$0 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

70 is the average number of prescriptions (including refills) per patient, compared to an average of 35.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
OMEPRAZOLE 978 845 1 5
SIMVASTATIN 767 683 2 2
LISINOPRIL 692 610 3 4
FUROSEMIDE 688 598 4 3
AMLODIPINE BESYLATE 486 436 5 7
METOPROLOL SUCCINATE 467 444 6 23
METOPROLOL TARTRATE 459 400 7 8
ATORVASTATIN CALCIUM 413 360 8 13
HYDROCODONE-ACETAMINOPHEN 411 362 S3 9 15
LEVOTHYROXINE SODIUM 407 365 10 6
TRAZODONE HCL 391 295 11 11
LANTUS 344 250 12 26
CITALOPRAM HBR 341 277 13 12
WARFARIN SODIUM 318 297 14 1
SPIRIVA 309 264 15 31
SERTRALINE HCL 289 255 16 10
METFORMIN HCL 284 230 17 20
GABAPENTIN 276 200 18 19
TRAMADOL HCL 270 210 19 34
ADVAIR DISKUS 249 195 20 39
CYMBALTA 245 208 21 33
HYDROCHLOROTHIAZIDE 229 218 22 14
POLYETHYLENE GLYCOL 3350 219 207 23 24
TAMSULOSIN HCL 206 197 24 21
ZOLPIDEM TARTRATE 204 175 25 41
DONEPEZIL HCL 185 181 26 9
PRAVASTATIN SODIUM 184 160 27 28
DIOVAN 177 132 28 30
PANTOPRAZOLE SODIUM 175 108 29 32
VENTOLIN HFA 166 144 30 86
ATENOLOL 160 143 31 17
METFORMIN HCL ER 158 135 32 82
GLIPIZIDE XL 157 157 33 104
PREDNISONE 154 139 34 40
QUETIAPINE FUMARATE 151 126 35 22
MELOXICAM 151 123 35 67
MIRTAZAPINE 142 138 37 16
ALENDRONATE SODIUM 138 111 38 25
CLOPIDOGREL 138 119 38 34
NAMENDA 130 130 40 18
LOSARTAN POTASSIUM 126 118 41 27
ISOSORBIDE MONONITRATE ER 122 120 42 48
ESCITALOPRAM OXALATE 121 121 43 38
INSULIN SYRINGE 118 81 44 120
ALLOPURINOL 115 108 45 29
CARBIDOPA-LEVODOPA 112 105 46 53
OXYCONTIN 111 103 S2 47 64
RISPERIDONE 110 88 48 36
DOXAZOSIN MESYLATE 103 91 49 70
PLAVIX 97 85 50 60
LIDODERM 94 73 51 55
CARVEDILOL 91 46 52 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 65 53 81
CELEBREX 87 83 54 106
PAROXETINE HCL 85 85 55 68
RANITIDINE HCL 85 67 55 51
FLUTICASONE PROPIONATE 80 77 57 58
GLIPIZIDE 80 74 57 42
DIVALPROEX SODIUM 79 62 59 69
VENLAFAXINE HCL ER 78 65 60 49
MECLIZINE HCL 77 73 61 77
LOPERAMIDE 75 45 62 147
ALBUTEROL SULFATE 75 63 62 88
HUMALOG 74 46 64 99
NEXIUM 71 58 65 78
LOVASTATIN 67 67 66 44
DILTIAZEM 24HR CD 67 67 66 61
LYRICA 65 61 68 97
IPRATROPIUM-ALBUTEROL 61 57 69 45
SINGULAIR 60 51 70 92
CIPROFLOXACIN HCL 60 55 70 57
EXELON 59 59 72 56
GLYBURIDE 58 46 R 73 76
OXYCODONE-ACETAMINOPHEN 58 43 S2 73 85
ABILIFY 58 43 73 115
BUSPIRONE HCL 58 36 73 91
CRESTOR 57 35 77 50
TOPIRAMATE 55 24 78 174
MORPHINE SULFATE ER 53 53 S2 79 114
NAPROXEN 53 53 79 89
RAMIPRIL 51 51 81 52
ENDOCET 51 51 S2 81 184
KLOR-CON M20 50 33 83 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.